Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
938 A spatially optimized long-acting gp100×CD3×albumin trispecific antibody enables durable antitumor immunity in gp100-expressing solid tumors
7 affiliations
- 1Department of Neurosurgery, Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing, China
- 2PhD student
- 33 Lymphoma Diagnosis and Treatment Centre of Henan Province, Zhengzhou, Henan, China
- 4Shanghai Children’s Hospital, Department of Otolaryngology and Head and Neck Surgery, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- 5Department of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- 6Biocytogen Pharmaceuticals, Beijing, China
- 7Biocytogen, Waltham, MA, USA
Related
- Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models
- A signaling-optimized TIGIT chimeric switch receptor promotes metabolic fitness and antitumor efficacy of TCR/CAR T cells
- Adenoviral vector co-expressing ALDH1 and ADH1 mitigates alcohol toxicity and modulates glucose and lipid metabolism
- The fraction of CD117/c-KIT-expressing erythroid precursors predicts ESA response in low-risk myelodysplastic syndromes.
- LGR5 and SOX2 expressing progenitor cells in the adult and aged human and mouse inner ear have the potential to produce Myosin 7A positive cells in vitro
BibTeX
@article{yang2026spatially,
title = {{938 A spatially optimized long-acting gp100×CD3×albumin trispecific antibody enables durable antitumor immunity in gp100-expressing solid tumors}},
author = {Yi Yang and Xue Li and Yue Zhang and Limin Zhao and Jun Du and Xin Jiao and Icy Niu},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0938},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0938},
note = {CC BY},
}
RIS
TY - JOUR
TI - 938 A spatially optimized long-acting gp100×CD3×albumin trispecific antibody enables durable antitumor immunity in gp100-expressing solid tumors
AU - Yi Yang
AU - Xue Li
AU - Yue Zhang
AU - Limin Zhao
AU - Jun Du
AU - Xin Jiao
AU - Icy Niu
PY - 2026
DA - 2026/11/07
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0938
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0938
SN - 2051-1426
ER -